Alcolase
Alcolase

Alcolase

DR12Ahrefs DR: 12/100. Bottom 25%. Measured by Ahrefs. Median 44.eDR26Effective DR: 26/100. Bottom 25%. Measured by StartupHub.ai. Median 68.Agent46Agent Readiness: 46/100. Above median. Measured by StartupHub.ai. Median 41.Speed48Site Speed: 48/100. Bottom 25%. Measured by Google PageSpeed. Median 62.

Alcolase is a Danish biotech startup developing an enzyme-based technology designed to break down alcohol in the stomach before it is absorbed into the bloodstream.

Website
2020Active8Copenhagen, Denmark

About

Alcolase is a Danish biotech company developing an enzyme-based technology for alcohol intolerance, specifically targeting individuals with ALDH2 deficiency, a genetic variant common in East Asia. Their first product is a liposomal enzyme system designed to break down alcohol in the stomach before it reaches the bloodstream, aiming to reduce symptoms like flushing, nausea, and discomfort. The company also has a UK therapeutic subsidiary to explore broader drug delivery applications of its platform.

Key facts

At-a-glance profile data

Website
alcolase.com
Headquarters
Copenhagen, Denmark
Founded
2020
Employees
8
Total funding
-
Business model
B2C

Tech stack

Detected on alcolase.com, last scanned 18 Sept 2026. Run your own scan

CMS / Builders
Squarespace
Email provider
Google Workspace
Add first review

Frequently asked

Is Alcolase trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Alcolase is 74 out of 100, based on site security posture and privacy practices.

How many employees does Alcolase have?

Alcolase has approximately 8 people on record.